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In this issue of Blood, Dertschnig and colleagues 1 demonstrate in mice that acute graft-versus-host disease (GHVD) results in a marked reduction of autoimmune receptor-expressing medullary thymic epithelial cells (Aire 1 mTEC) and a decrease in the diversity of Aire-dependent tissue-restricted peripheral selfantigens (TRAs) required for effective negative thymic selection. Both of these abnormalities are reversed by the peritransplant administration of the epithelial protectant drug, fibroblast growth factor 7(Fgf7).
C
hronic GVHD continues to be a major cause of both morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). 2 Chronic GVHD has been assumed to be caused by the continuation of the pathogeneic mechanisms that cause acute GVHD, primarily donorderived T lymphocytes specific for histocompatibility antigens uniquely expressed by recipient cells. 3 As a consequence, therapy for chronic GVHD has traditionally been directed at suppressing the donor antirecipient immune response. However, during the last 25 years, a series of murine experiments have indicated that donor-derived, autoreactive T lymphocytes (ie, T lymphocytes specific for antigens expressed by both donor and recipient cells) are present in murine HSCT recipients with chronic GVHD and that the chronic GVHD could be transferred by the donorderived T lymphocytes into both donor and recipient mice. Finally, the present results suggest that the focus of future research into new therapies to prevent or treat chronic GVHD should be directed at the thymic microenvironment rather than at lymphohematopoietic cells.
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In this issue of Blood, Moxon et al provide novel insight into the pathogenesis of cerebral malaria, linking loss of the endothelial protein C receptor (EPCR) on brain vessels, caused by cytoadherent infected erythrocytes, with localized coagulation, inflammation, and disruption of endothelial barrier function. 1 M alaria is caused by parasites of the genus Plasmodium, of which P falciparum is the most virulent. 2 One of the most fatal manifestations of P falciparum infection is cerebral malaria, which especially affects children ,6 years of age and is responsible for an annual death toll of nearly a million infants in Africa alone. In recent years, the cycle of coagulation and inflammation has emerged as a pivotal component of malaria pathogenesis. 3 In normal homeostasis, activation of coagulation is compensated by concurrent induction of anticoagulant mechanisms. 4 In areas of excessive activation of the clotting cascade, thrombin acts as a feedback inhibitor of coagulation by binding to the endothelial receptor thrombomodulin (see figure) . The thrombomodulin-thrombin complex converts the zymogen protein C into activated protein C (APC), a reaction that is greatly accelerated by EPCR. A hallmark feature of severe malaria is sequestration of infected erythrocytes in blood vessels. 2 The elegant investigations by
Moxon et al provide a long-sought explanation of why red blood cell sequestration especially leads to damage in the brain. 1 In postmortem studies in children that had died of cerebral malaria, endothelial sites of adherent erythrocytes were shown to colocalize with loss of EPCR. Moreover, the authors developed a novel approach that enabled examination of blood vessels with relevance for the brain vasculature in children with cerebral malaria directly after admission to the hospital. For this, they used subcutaneous tissue microvessels as an ex vivo surrogate for brain endothelium and demonstrated reduced expression of both EPCR and thrombomodulin in cerebral malaria patients compared with healthy controls. Children with cerebral malaria had higher levels of soluble EPCR and thrombomodulin in their cerebrospinal fluid than febrile control patients, suggesting that the loss of these receptors at least in part was caused by shedding. Importantly, in plasma, the balance between the production of thrombin (measured by the levels of the prothrombin F112 fragment) and APC was not altered in cerebral malaria compared with healthy children and children with mild febrile disease or uncomplicated malaria, indicating that at the systemic level, coagulation activation was compensated. Together, these data strongly suggest that cerebral malaria is associated with a localized disturbance of coagulation and inflammation caused by a local loss of EPCR and thrombomodulin initiated by sequestration of infected erythrocytes, changes that damage the brain due to the already low constitutive expression of EPCR and thrombomodulin in healthy brain vessels. 1, 7 Another recent study has implicated EPCR in the pathogenesis of malaria by a completely different mechanism. 8 In malaria, adherence of red blood cells to endothelium is caused by an interaction between P falciparum erythrocyte membrane protein-1 (PfEMP1) family members, transported to the erythrocyte membrane as a consequence of parasite infection, and receptors on the vascular endothelium. 2 In this respect, PfEMP1 subtypes containing domain cassettes 8 and 13 are important for sequestration of infected erythrocytes in severe childhood malaria.
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Turner et al very recently revealed EPCR as the endothelial receptor for PfEMP1 domain
